As the worldwide leader in styrenics, INEOS Styrolution supports stakeholders in the healthcare sector in meeting their increasing challenges in material selection for medical device improvements.  Based on a deep understanding of the medical industry, its applications, value chains and regulatory requirements, INEOS Styrolution continuously renews and improves its portfolio and services to generate further value for its customers.

With wide-reaching expertise and a dedication to unparalleled service, INEOS Styrolution offers a broad range of products dedicated to healthcare, top quality styrenic solutions for new applications, product co-development opportunities, and comprehensive assistance with strict regulatory requirements.

In this webinar, we will talk about two key resins in our healthcare portfolio. Zylar® is an impact modified styrene acrylic copolymer offering excellent clarity, superior processing, and an attractive balance of toughness and stiffness. Lustran® 348 is a Acrylonitrile Butadiene Styrene (ABS) resin with an exceptional balance of physical and mechanical properties, as well as excellent chemical resistance to common healthcare cleaner and disinfectants.  Both materials come with robust regulatory support in the form of our Full Service and Essential HD Packages, which include biocompatibility statements, a Drug Master File, and other critical healthcare regulatory support.

Experts featuring this session

Alex Silvestre, Global Director, Healthcare

Lisa Lindsley, Market Development Manager, Healthcare

Steven DeLisle, Market Development Manager, Healthcare